Technology is constantly evolving, and disruptive innovation is pushing the boundaries of cardiothoracic therapeutics. The growing acceptance of less invasive transcatheter interventions, for example, has made it one of the more explored surgical modalities. This progressive technology in cardiothoracic surgery was underscored in many sessions at this year’s meeting of The Society of Thoracic Surgeons (STS) in San Diego.